Learning Objectives:

1. Review the current status of neoadjuvant therapy in breast Cancer

2. Discuss disparities in response neoadjuvant therapy

3.Propose a clinical trial of neoadjuvant endocrine-based therapy for the most common subtype of breast cance.


Session date: 
04/20/2020 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Meghan Steiner, MD